CESAR: Center for Substance Abuse Research

What's New

NBC's NEWS4 I-Team Investigates Synthetic Drugs in the DC Area

January 2016

The NEWS4 I-Team has conducted a series of investigations into synthetic drugs in the DC area, several of which include interviews with CESAR's Director, Dr. Eric Wish. Visit the  website, Synthetics: The New Drug War at http://data.nbcstations.com/national/DC/synthetic-drugs/ for more information.

CESAR Director Dr. Eric Wish Talks About Synthetic Cannabinoids in DC on the Kojo NNamadi Show

July 2015

The July 23rd Kojo Nnamadi Show segment, Synthetic Cannabinoids and Public Health, featured CESAR Director, Dr. Eric Wish, Washington Post reporter Peter Hermann, the Director of the Community for Creative Nonviolence, Donald Page, and the Director of the D.C. Department of Public Health, Dr. LaQuandra Nesbitt. The show is available online at https://thekojonnamdishow.org/shows/2015-07-23/synthetic-marijuana-in-d-c.

Washington Post Article: "The Scariest Thing About Synthetic Drugs Is Everything That's Unknown"

July 2015

CESAR Director Dr. Eric Wish is quoted in the July 18th Washington Post article, "The Scariest Thing About Synthetic Drugs Is Everything That's Unknown," discussing synthetic drugs.


CESAR Director Dr. Eric Wish Interviewed About Synthetic Cannabinoids

July 2015

CESAR Director Dr. Eric Wish was recently interviewed by Al Jazeera America about synthetic cannabinoids. According to Dr. Wish, "When someone takes this drug, they are literally playing Russian Roulette. They do not know what's in it and they do not know how it's going to affect them. It may have been fine with a different batch or with a different friend, but it may all change when they take it." The interview can be viewed online at . In June, Dr. Wish talked with WAMU on why DC is cracking down on stores selling synthetic drugs ().

Second CDEWS Study Finds Synthetic Cannabinoids in Adults and Juveniles in Washington, DC, Denver, and Tampa Criminal Justice Populations

May 2015

The Community Drug Early Warning System (CDEWS) provides information about emerging drug use in local communities by sampling anonymous urine specimens that were previously collected by a criminal justice agency, tested for a limited panel of drugs, and are ready to be discarded. CDEWS re-tests the specimens for an expanded panel of more than 75 drugs. The second CDEWS study found that the types of SC metabolites detected vary considerably by site and that DC juveniles may be using different formulations of SC than DC adults. Implications for law enforcement and public health are also discussed in the report. For more information, see the CDEWS-2 report or the CESAR FAX issue highlighting the report. The first CDEWS report, published in 2013, can be found here.